PINK:SKYE

Skye Bioscience Stock Predictions

etoro logo Buy SKYE
*Your capital is at risk
$0.770
+0.0563 (+7.89%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

SKYE Prediction Chart

SKYE Predictions History

Latest community submissions for SKYE.
Predictor Target Session Target Price Result Direction Accuracy Score
Oct 6, 2025 $4.61 -2.85% $1.90 V 0.00% 1
Oct 6, 2025 $4.67 -1.78% $1.90 V 0.00% 1
Oct 6, 2025 Bullish $1.90 X 0
Aug 5, 2025 $3.49 -3.96% $3.79 X 91.98% 0
Aug 5, 2025 $3.72 +2.48% $3.79 V 98.15% 1
Aug 5, 2025 Bullish $3.79 V 1
Aug 1, 2025 $3.72 +4.19% $3.41 X 90.92% 0
Aug 1, 2025 $3.66 +2.62% $3.41 X 92.57% 0
Aug 1, 2025 Bullish $3.41 X 0
JS JS Pro
Apr 19, 2021 $0.119 -99.60% Awaiting close 100.00% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SKYE with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT SKYE BIOSCIENCE, INC.
Skye Bioscience
Skye Bioscience, Inc., a biopharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. The company's lead product candidate is SBI-100, which is in Phase I trials for the treatment of glaucoma and ocular hypertension. It is also developing SBI-200 that is in preclinical trials to treat and manage various eye diseases, including uveitis, dry eye syndrome, macular degenerati...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE